Published on
Pathology- Multiple Sclerosis (MS)
This guide summarizes key information on Multiple Sclerosis to aid understanding and effective study.
I. Definition & Epidemiology:
  • Definition: MS is a relapsing-remitting, demyelinating disease of the Central Nervous System (CNS). Neurological disturbances affect different CNS areas at different times. Think intermittent attacks in different locations.
  • Epidemiology:
    • Peak onset: 20-30 years old.
    • Slightly more common in females.
    • Significant geographical variation: higher incidence at higher latitudes (farther from the equator), near absence near the equator. This hints at environmental factors.
II. Aetiology & Pathogenesis:
  • Aetiology (Cause): Unknown. Leading hypothesis: immune-mediated demyelination triggered by a childhood infection in genetically susceptible individuals. Think infection + genetics = trigger.
  • Pathogenesis (Mechanism):
    • Demyelination episodes cause acute neurological deficits (symptoms) developing over days and lasting weeks.
    • Early stages: Complete recovery is typical.
    • Progression: Slower recovery, residual deficits, axonal death, and permanent disability due to extensive axonal loss. Think initial recovery, then progressive damage.
III. Clinical Presentation: (Note the association between location of demyelination and symptoms)
  • Optic Nerve: Blurred vision, loss of color vision.
  • Cerebellum: Vertigo, incoordination.
  • Brainstem: Eye movement disorders.
  • Spinal Cord: Patchy numbness/tingling, progressing to paraplegia (paralysis of lower limbs), incontinence, and sexual dysfunction.
IV. Macroscopic & Microscopic Findings:
  • Macroscopy (Gross Examination): Well-circumscribed grey plaques in CNS white matter. Common locations: optic nerves, periventricular white matter, brainstem, cervical spinal cord. Think visible lesions in specific areas.
  • Histopathology (Microscopic Examination):
    • Active plaques: Inflammatory infiltrate, myelin sheath destruction.
    • Established plaques: Complete myelin loss, reduced oligodendrocytes (myelin-producing cells), relatively normal or slightly reduced axon numbers (initially).
V. Prognosis:
  • Most patients experience progressive disease.
  • Significant complications due to disability: pneumonia, urinary tract infections, pressure sores. Think disability leads to secondary complications.
Key Concepts to Remember:
  • Relapsing-remitting: Periods of attacks followed by periods of remission (partial or complete recovery).
  • Demyelination: Damage to the myelin sheath surrounding nerve fibers, impairing signal transmission.
  • Geographical variation: Strong evidence for environmental influence.
  • Progressive axonal loss: The ultimate cause of permanent disability.
  • Location-specific symptoms: The location of the demyelination dictates the presenting symptoms.
Picture
0 Comments